Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00060411
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.264478+00:00
Published At
2013-09-30T00:00:00+00:00
Record Updated At
2013-09-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mucinous Adenocarcinoma of the Colon", "Mucinous Adenocarcinoma of the Rectum", "Recurrent Colon Cancer", "Recurrent Rectal Cancer", "Signet Ring Adenocarcinoma of the Colon", "Signet Ring Adenocarcinoma of the Rectum", "Stage IIIA Colon Cancer", "Stage IIIA Rectal Cancer", "Stage IIIB Colon Cancer", "Stage IIIB Rectal Cancer", "Stage IIIC Colon Cancer", "Stage IIIC Rectal Cancer", "Stage IVA Colon Cancer", "Stage IVA Rectal Cancer", "Stage IVB Colon Cancer", "Stage IVB Rectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-09-30"
protocolSection.identificationModule.nctId
"NCT00060411"
protocolSection.identificationModule.officialTitle
"A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mucinous Adenocarcinoma of the Colon (protocolSection.conditionsModule.conditions)
  • Mucinous Adenocarcinoma of the Rectum (protocolSection.conditionsModule.conditions)
  • Recurrent Colon Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Signet Ring Adenocarcinoma of the Colon (protocolSection.conditionsModule.conditions)
  • Signet Ring Adenocarcinoma of the Rectum (protocolSection.conditionsModule.conditions)
  • Stage IIIA Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Rectal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.